Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022
[266 Pages Report] The global clinical trial management system (CTMS) market is expected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. Factors such as significant outsourcing of clinical trial research to CROs, rising number of clinical trials, availability of advanced CTMS solutions, and rising government funds & grants to support clinical trials are driving the overall demand for CTMS across key markets.
By type, the enterprise CTMS segment is expected to be the largest segment of the CTMS market in 2017
This report broadly segments the CTMS market into type, delivery mode, component, end user, and region. On the basis of by type, the CTMS market is segmented into enterprise CTMS and site CTMS. The enterprise CTMS segment is expected to command the largest share of the global CTMS market in 2017 and is expected to grow at the highest CAGR in the forecast period. This is attributed to the global adoption of enterprise CTMS by majority of the end users.
By end user, the contract research organizations segment is expected to grow at the highest rate during the forecast period
By end user, the CTMS market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment is sub-segmented into large pharmaceutical companies and mid-small pharmaceutical companies. The contract research organizations segment is expected to grow at the fastest rate during the forecast period in 2017. This is attributed to the rise in outsourcing of clinical trials by pharma and biotechnology companies to CROs.
North America dominated the market in 2017
On the basis of region, CTMS market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate the global CTMS market primarily due to the high number of ongoing clinical trials, rising government support for conducting clinical trials, and presence of a large customer base in this region.
Market Dynamics
Factors such as significant partnerships between biopharma companies and CROs, rising number of clinical trials, availability of advanced CTMS solutions, growing customer base for CTMS solutions, and rising government funding & grants to support clinical trials are driving the overall demand for CTMS across key markets. However, budget constraints and limited awareness among researchers about the advantages of CTMS solutions are the major factors restraining the growth of CTMS market.
Driver: Rising number of clinical trials to drive the CTMS market
The life science industry is witnessing a global increase in the number of clinical trials each year. This growth in the number of clinical trials conducted can be attributed to factors such as the rapidly increasing aging population, high prevalence of chronic diseases, expiry of blockbuster drugs, availability of government funds for clinical trials, and fierce competition in the pharmaceutical industry. According to ClinicalTrials.gov, as of December 06, 2017, 260,848 clinical trials were registered across the globe.
As CTMS solutions are predominantly used to manage clinical trials, the global rise in the number of clinical trials is directly contributing to the increase in the demand for CTMS solutions.
Restraint: Limited awareness among researchers about the advantages of CTMS solutions
Several investigators are either unaware or ignorant of the benefits of CTMS over traditional paper-based work or spreadsheets method. Clinical trial investigators need to understand the prospects of these tools which enhance the clinical trial process and help manage it effectively. This limited awareness in the research community is consequently limiting the adoption of CTMS solutions.
Scope of the Report
|
Report Metric |
Details |
|
Market Size Available for Years |
20152022 |
|
Base Year Considered |
2016 |
|
Forecast Period |
20172022 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Type, delivery mode, component, end user, and region |
|
Geographies Covered |
North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW |
|
Companies Covered |
Oracle Corporation (US), Medidata Solutions, Inc. (US), PAREXEL International Corporation. (US), Bioclinica. (US), Bio-Optronics, Inc. (US), IBM (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), and DZS Software Solutions (US) |
This report categorizes the CTMS market into the following segments and subsegments:
Global Clinical Trial Management Systems Market, by Type
- Enterprise CTMS
- Site CTMS
Global Clinical Trial Management Systems Market, by Delivery Mode
- Web-Based (Hosted) CTMS
- Licensed Enterprise (On Premise) CTMS
- Cloud-Based (SaaS) CTMS
Global Clinical Trial Management Systems Market, by Component
- Software
- Service
Global Clinical Trial Management Systems Market, By End User
- Pharmaceutical and Biopharmaceutical Companies
- Large Pharmaceutical Companies
- Mid-Small Pharmaceutical Companies
- Contract Research Organizations
- Medical Device Companies
- Other End Users
Global Clinical Trial Management Systems Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Rest of Europe (RoE)
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
- Rest of the World (RoW)
Key Market Players
As of 2016, the global clinical trial management systems market was dominated by Oracle Corporation (US), Medidata Solutions, Inc. (US), PAREXEL International Corporation (US), Bioclinica. (US), Bio-Optronics, Inc. (US), IBM (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), and DZS Software Solutions (US).
Oracle (US) is the leading player in the global CTMS solutions market. The companys diversified geographic presence and customer base contributes to its leading position in the market. The company focuses on collaborations and alliances with leading biopharmaceutical companies to enhance its customer base across the globe. For instance, in February 2016, the company provided its eClinical solutions, including CTMS solutions to Bayer AG (Germany) to manage its clinical trials. The growing demand for cloud computing services and mobile computing services will offer new growth opportunities for Oracle Corporation. Furthermore, the large repositories of the company, including unstructured information created by new applications, will help the company to secure its leading position in this market.
Medidata (US) is one of the leading players in the global CTMS solutions market. The company has a strong partnering network, which enables it to enhance its presence across the globe and hold a significant market share. In addition, the company is a leading global provider of cloud (software-as-a-service) solutions. It mainly focuses on partnerships and collaborations as its key strategy to expand its presence in the CTMS solutions market. It focuses on partnerships with various CROs and pharmaceutical customers. Also, it strategically invests in R&D activities to develop innovative solutions in order to help customers accelerate commercialization of their products. Owing to its continuous innovation activities, many pharmaceutical players such as Boehringer Ingelheim (Germany), Celgene (US), and Bristol-Myers Squibb (US) selected Medidata as their CTMS vendor. This helped the company to increase its share in the CTMS market.
Recent Developments:
- In November 2017, Bio-Optronics and Complion entered into a partnership in order to integrate and develop their solutions, namely, CTMS and eRegulatory Solutions
- In September 2017, Pamplona completed the acquisition of Paraxel and bought its shares in order to help PARAXEL increase its productivity.
- In May 2017, Oracle opened its Oracle Cloud EU Region in Germany, with the addition of modern infrastructure as a service (IaaS) architecture and new IaaS and platform as a service (PaaS) cloud services.
- In January 2017, MedNet Solutions released the latest version of iMedNet with enhanced features
- In June 2016, Bio-Optronics launched the latest version of the Clinical Conductor CTMS.
Key questions addressed in the report:
- What are the growth opportunities related to CTMS market across major regions in the future?
- Emerging countries have immense opportunities for the growth and adoption of enterprise CTMS products. Will this scenario continue in the next five years?
- What are the various types of CTMS products and their market share in the overall market?
- What are the new trends and advancements in the clinical trials industry?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used
1.5 Market Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary
4 Premium Insights
4.1 Clinical Trial Management System Market: Overview (20172022)
4.2 Global Clinical Trial Management Systems Market, By Component, 2017 vs 2022
4.3 Global Clinical Trial Managements Systems Market, By Type, 2017 vs 2022
4.4 Global Clinical Trial Management Systems Market, By End-User and Mode of Delivery (2017)
4.5 Global Clinical Trial Management Systems Market, By Country, 2017
5 Clinical Trial Management System Market: Overview
5.1 Drivers
5.2 Restraints
5.3 Opportunities
5.4 Challenges
5.5 Key Industry Trends
6 Clinical Trial Management Systems Market, By Type
6.1 Introduction
6.2 Enterprise CTMS
6.3 Site CTMS
7 Clinical Trial Management Systems Market, By Delivery Mode
7.1 Introduction
7.2 Web-Based (Hosted) CTMS
7.3 Licensed Enterprise (On Premise) CTMS
7.4 Cloud-Based (SaaS) CTMS
8 Clinical Trial Management Systems Market, By Component
8.1 Introduction
8.2 Softwares
8.3 Services
9 Clinical Trial Management Systems Market, By End User
9.1 Introduction
9.2 Pharmaceutical and Biopharmaceutical Companies
9.2.1 Large Pharmaceutical Companies
9.2.2 Mid-Small Pharmaceutical Companies
9.3 Contract Research Organizations
9.4 Medical Device Companies
9.5 Other End Users
10 Clinical Trial Management Systems Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Rest of Europe (RoE)
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World (RoW)
11 Competitive Landscape
11.1 Overview
11.2 Clinical Trial Management Systems Market Share Analysis, By Key Players (2016)
11.3 Competitive Scenario and Trends
11.3.1 Product Launches and Enhancements (20142017)
11.3.2 Agreements, Partnerships, and Collaborations (20142017)
11.3.3 Market Expansions (20142017)
11.3.4 Mergers and Acquisitions (20142017)
*Top 15 Companies Analyzed for This Studies are - Oracle (US), Medidata Solutions (US), Parexel (US), Bioclinica (US), Bio-Optronics (US), IBM (US), Datatrak (US), Veeva Systems (US), DSG (US), Mastercontrol (US), ERT (US), Forte Research Systems (US), Mednet Solutions (US), Arisglobal (US), and DZS Software Solutions (US).
12 Company Profiles
(Introduction, Products & Services, Financial Snapshots, Developments, MnM View)*
12.1 Oracle
12.2 Medidata Solutions
12.3 Parexel
12.4 Bioclinica
12.5 Bio-Optronics
12.6 IBM
12.7 Datatrak
12.8 Veeva Systems
12.9 DSG
12.10 Mastercontrol
12.11 ERT
12.12 Forte Research Systems
12.13 Mednet Solutions
12.14 Arisglobal
12.15 DZS Software Solutions
*Details on Marketsandmarkets View, Introduction, Product & Services, New Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
13.6 Authors Details
List of Tables (88 Tables)
Table 1 List of Partnerships Between Biopharma Companies and CROs
Table 2 Global Clinical Trial Management System Market, By Type, 20172022 (USD Million)
Table 3 CTMS Market for Enterprise CTMS, By Region, 20172022 (USD Million)
Table 4 CTMS Market for Site CTMS, By Region, 20172022 (USD Million)
Table 5 Global CTMS Market, By Delivery Mode, 20152022 (USD Million)
Table 6 Web-Based (On-Demand) Clinical Trial Management Systems Market, By Region, 20152022 (USD Million)
Table 7 Licensed Enterprise (On-Premise) CTMS Market, By Region, 20152022 (USD Million)
Table 8 Cloud-Based (SaaS) Clinical Trial Management Systems Market, By Region, 20152022 (USD Million)
Table 9 Global CTMS Market, By Component, 20172022 (USD Million)
Table 10 CTMS Market for Software By Region, 20172022 (USD Million)
Table 11 CTMS Market for Services By Region, 20172022 (USD Million)
Table 12 Global Clinical Trial Management Systems Market, By End User, 20172022 (USD Million)
Table 13 CTMS Market for Pharmaceutical and Biopharmaceutical Companies By Region, 20172022 (USD Million)
Table 14 Clinical Trial Management System Market for Pharmaceutical and Biopharmaceutical Companies By Type, 20172022 (USD Million)
Table 15 CTMS Market for Large Pharmaceutical Companies By Region, 20172022 (USD Million)
Table 16 Clinical Trial Management Systems Market for Small-Mid Sized Pharamceutical Companies By Region, 20172022 (USD Million)
Table 17 Strategic Alliances Between CROs and Pharma Companies (20112015)
Table 18 Clinical Trial Management System Market for CRO By Region, 20172022 (USD Million)
Table 19 CTMS Market for Medical Device Companies By Region, 20172022 (USD Million)
Table 20 CTMS Market for Other End Users By Region, 20172022 (USD Million)
Table 21 Clinical Trial Management Systems Market, By Region, 20152022 (USD Million)
Table 22 North America: Clinical Trial Management System Market, By Country, 20152022 (USD Million)
Table 23 North America: Market, By Component, 20152022 (USD Million)
Table 24 North America: CTMS Market, By Type, 20152022 (USD Million)
Table 25 North America: Clinical Trial Management Systems Market, By Delivery Mode, 20152022 (USD Million)
Table 26 North America: CTMS Market, By End User, 20152022 (USD Million)
Table 27 North America: Pharmaceutical and Biopharmaceutical Companies Market, By Type, 20152022 (USD Million)
Table 28 US: Clinical Trial Management Systems Market, By Component, 20152022 (USD Million)
Table 29 US: CTMS Market, By Component, 20152022 (USD Million)
Table 30 US: Clinical Trial Management System Market, By Delivery Mode, 20152022 (USD Million)
Table 31 US: CTMS Market, By End User, 20152022 (USD Million)
Table 32 Canada: Clinical Trial Management Systems Market, By Component, 20152022 (USD Million)
Table 33 Canada: CTMS Market, By Type, 20152022 (USD Million)
Table 34 Canada: Clinical Trial Management System Market, By Delivery Mode, 20152022 (USD Million)
Table 35 Canada: Market, By End User, 20152022 (USD Million)
Table 36 Europe: Clinical Trial Management Systems Market, By Country, 20152022 (USD Million)
Table 37 Europe : CTMS Market, By Component, 20152022 (USD Million)
Table 38 Europe : CTMS Market, By Type, 20152022 (USD Million)
Table 39 Europe : Clinical Trial Management System Market, By Delivery Mode, 20152022 (USD Million)
Table 40 Europe : Clinical Trial Management Systems Market, By End User, 20152022 (USD Million)
Table 41 Europe : Pharmaceutical and Biopharmaceutical Companies Market, By Type, 20152022 (USD Million)
Table 42 Germany: Market, By Component, 20152022 (USD Million)
Table 43 Germany: CTMS Market, By Type, 20152022 (USD Million)
Table 44 Germany: Clinical Trial Management Systems Market, By Delivery Mode, 20152022 (USD Million)
Table 45 Germany: Clinical Trial Management System Market, By End User, 20152022 (USD Million)
Table 46 UK: Clinical Trial Management Systems Market, By Component, 20152022 (USD Million)
Table 47 UK: CTMS Market, By Type, 20152022 (USD Million)
Table 48 UK: CTMS Market, By Delivery Mode, 20152022 (USD Million)
Table 49 UK: Clinical Trial Management System Market, By End User, 20152022 (USD Million)
Table 50 France: Clinical Trial Management Systems Market, By Component, 20152022 (USD Million)
Table 51 France: CTMS Market, By Type, 20152022 (USD Million)
Table 52 France : Market, By Delivery Mode, 20152022 (USD Million)
Table 53 France : Clinical Trial Management System Market, By End User, 20152022 (USD Million)
Table 54 RoE: Clinical Trial Management Systems Market, By Component, 20152022 (USD Million)
Table 55 RoE: CTMS Market, By Type, 20152022 (USD Million)
Table 56 RoE: CTMS Market, By Delivery Mode, 20152022 (USD Million)
Table 57 RoE: Market, By End User, 20152022 (USD Million)
Table 58 APAC: Clinical Trial Management Systems Market, By Country, 20152022 (USD Million)
Table 59 APAC: CTMS Market, By Component, 20152022 (USD Million)
Table 60 APAC: Clinical Trial Management System Market, By Type, 20152022 (USD Million)
Table 61 APAC: CTMS Market, By Delivery Mode, 20152022 (USD Million)
Table 62 APAC: Clinical Trial Management Systems Market, By End User, 20152022 (USD Million)
Table 63 APAC: Pharmaceutical and Biopharmaceutical Companies Market, By Type, 20152022 (USD Million)
Table 64 China: Clinical Trial Management Systems Market, By Component, 20152022 (USD Million)
Table 65 China: Market, By Type, 20152022 (USD Million)
Table 66 China: CTMS Market, By Delivery Mode, 20152022 (USD Million)
Table 67 China: CTMS Market, By End User, 20152022 (USD Million)
Table 68 Japan: Clinical Trial Management Systems Market, By Component, 20152022 (USD Million)
Table 69 Japan: CTMS Market, By Type, 20152022 (USD Million)
Table 70 Japan: Market, By Delivery Mode, 20152022 (USD Million)
Table 71 Japan: Clinical Trial Management System Market, By End User, 20152022 (USD Million)
Table 72 India: Clinical Trial Management Systems Market, By Component, 20152022 (USD Million)
Table 73 India: CTMS Market, By Type, 20152022 (USD Million)
Table 74 India: CTMS Market, By Delivery Mode, 20152022 (USD Million)
Table 75 India: CTMS Market, By End User, 20152022 (USD Million)
Table 76 RoAPAC: Clinical Trial Management Systems Market, By Component, 20152022 (USD Million))
Table 77 RoAPAC: CTMS Market, By Type, 20152022 (USD Million)
Table 78 RoAPAC: Clinical Trial Management Systems Market, By Delivery Mode, 20152022 (USD Million))
Table 79 RoAPAC: CTMS Market, By End User, 20152022 (USD Million)
Table 80 RoW: Clinical Trial Management System Market, By Component, 20152022 (USD Million)
Table 81 RoW: Market, By Type, 20152022 (USD Million)
Table 82 RoW: Clinical Trial Management Systems Market, By Delivery Mode, 20152022 (USD Million)
Table 83 RoW: CTMS Market, By End User, 20152022 (USD Million)
Table 84 RoW: Pharmaceutical and Biopharmaceutical Companies Market, By Type, 20152022 (USD Million)
Table 85 Product Launches and Enhancements (20142017)
Table 86 Agreements, Partnerships, and Collaborations (20142017)
Table 87 Market Expansions (20142017)
Table 88 Mergers and Acquisitions (20142017)
List of Figures (46 Figures)
Figure 1 Clinical Trial Management System Market: Research Design
Figure 2 Breakdown of Primaries
Figure 3 Enterprise CTMS Segment to Hold the Largest Share of the Clinical Trial Management Systems Market in 2017
Figure 4 Software Segment to Hold the Largest Share in the CTMS Market During 20172022
Figure 5 Web-Based CTMS Segment to Hold the Largest Share in the Global Market During the Forecast Period
Figure 6 CTMS Market, By End User, 2017 vs 2022
Figure 7 North America to Dominate the Global Clinical Trial Management Systems Market During the Forecast Period
Figure 8 Rising Number of Clinical Trials to Drive the Growth of the Market (20172022)
Figure 9 Software Platforms to Dominate the Global Clinical Trial Management System Market Till 2022
Figure 10 Enterprise Based CTMS Platforms to Dominate the Global CTMS Market Till 2022
Figure 11 Web-Based CTMS and Pharmaceutical Companies to Dominate the CTMS Market in 2017
Figure 12 China to Be the Fastest-Growing Markets for CTMS During the Forecast Period
Figure 13 Market Dynamics: Driver, Restraints, Opportunities and Challenges
Figure 14 Global Increase in the Number of Clinical Trials, 20022017
Figure 15 Global Clinical Trial Management Systems Market Share, By Type, 2017 vs 2022
Figure 16 Enterprise CTMS Market Share, By Geography (2017)
Figure 17 Site CTMS Market Share, By Geography (2017)
Figure 18 Global CTMS Market, By Mode of Delivery (2017 vs 2022)
Figure 19 Web-Based (On-Demand) Segment to Dominate the Global CTMS Market in 2017
Figure 20 Web-Based (On Demand) Clinical Trial Management System Market Share, By Region(2017)
Figure 21 Licensed Enterprise (On-Premise) Clinical Trial Management Systems Market Share, By Region (2017)
Figure 22 Cloud-Based (SaaS) CTMS Market Share, By Region (2017)
Figure 23 Software Segment to Dominate the Global CTMS Solutions Market in 2017
Figure 24 Software Market Share, By Geography (2017)
Figure 25 Services Market Share, By Geography (2017)
Figure 26 Global Clinical Trial Management System Market, By End User, 2017
Figure 27 Pharmaceutical and Biopharmaceutical Companies Segment to Dominate the Global Market in 2017
Figure 28 R&D Expenditure of Major Pharmaceutical Companies, 2015 vs 2016 (USD Million)
Figure 29 Pharmaceutical Companies Market Share, By Geography (2017)
Figure 30 Large Pharmaceutical Companies Market Share, By Geography (2017)
Figure 31 Mid-Small Pharamceutical Companies Market Share, By Geography (2017)
Figure 32 CRO Services Cover the Entire Drug Development Spectrum
Figure 33 CRO Market Share, By Geography (2017)
Figure 34 Medical Device Companies Market Share, By Geography (2017)
Figure 35 Other End Users Market Share, By Geography (2017)
Figure 36 Clinical Trial Management Systems Market By Region (2017 vs 2022)
Figure 37 Total Number of Ongoing Clinical Trials, By Region (December 2017)
Figure 38 Europe: Pharmaceutical R&D Expenditure, By Country, 2015 (USD Million)
Figure 39 Key Developments By Leading Market Players in the CTMS Market, 2014-2017
Figure 40 Global CTMS Market Share Analysis, 2016
Figure 41 Oracle : Company Snapshot
Figure 42 Medidata Solutions: Company Snapshot
Figure 43 Parexel : Company Snapshot
Figure 44 IBM : Company Snapshot
Figure 45 Datatrak : Company Snapshot
Figure 46 Veeva Systems : Company Snapshot
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Clinical Trial Management System Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Clinical Trial Management System Market